Related Experiment Video
Updated: Apr 21, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Novel ThickNet features for the discrimination of amnestic MCI subtypes
Pradeep Reddy Raamana1, Wei Wen2, Nicole A Kochan2
1School of Engineering Science, Simon Fraser University, Burnaby V5A 1S6, Canada.
Background:
Amnestic mild cognitive impairment (aMCI) is considered to be a transitional stage between healthy aging and Alzheimer's disease (AD), and consists of two subtypes: single-domain aMCI (sd-aMCI) and multi-domain aMCI (md-aMCI). Individuals with md-aMCI are found to exhibit higher risk of conversion to AD. Accurate discrimination among aMCI subtypes (sd- or md-aMCI) and controls could assist in predicting future decline.
Methods:
We apply our novel thickness network (ThickNet) features to discriminate md-aMCI from healthy controls (NC). ThickNet features are extracted from the properties of a graph constructed from inter-regional co-variation of cortical thickness. We fuse these ThickNet features using multiple kernel learning to form a composite classifier. We apply the proposed ThickNet classifier to discriminate between md-aMCI and NC, sd-aMCI and NC and; and also between sd-aMCI and md-aMCI, using baseline T1 MR scans from the Sydney Memory and Ageing Study.
Results:
ThickNet classifier achieved an area under curve (AUC) of 0.74, with 70% sensitivity and 69% specificity in discriminating md-aMCI from healthy controls. The same classifier resulted in AUC = 0.67 and 0.67 for sd-aMCI/NC and sd-aMCI/md-aMCI classification experiments respectively.
Conclusions:
The proposed ThickNet classifier demonstrated potential for discriminating md-aMCI from controls, and in discriminating sd-aMCI from md-aMCI, using cortical features from baseline MRI scan alone. Use of the proposed novel ThickNet features demonstrates significant improvements over previous experiments using cortical thickness alone. This result may offer the possibility of early detection of Alzheimer's disease via improved discrimination of aMCI subtypes.
Insights
This study introduces ThickNet, a novel classifier for distinguishing subtypes of mild cognitive impairment (MCI). ThickNet shows promise in identifying individuals with multi-domain MCI (md-MCI) at higher risk for Alzheimer's disease progression.
Area of Science:
- Neuroimaging
- Machine Learning
- Cognitive Neuroscience
Background:
- Amnestic mild cognitive impairment (aMCI) is a precursor to Alzheimer's disease (AD).
- aMCI has subtypes: single-domain (sd-aMCI) and multi-domain (md-aMCI).
- md-aMCI carries a higher risk of progression to AD.
Purpose of the Study:
- To develop and evaluate a novel classifier, ThickNet, for discriminating between aMCI subtypes and healthy controls.
- To assess the potential of ThickNet for early detection of Alzheimer's disease by identifying individuals at risk.
Main Methods:
- Utilized novel Thickness Network (ThickNet) features derived from cortical thickness co-variation graphs.
- Employed multiple kernel learning to fuse ThickNet features for a composite classifier.
- Applied the ThickNet classifier to baseline T1 MRI scans from the Sydney Memory and Ageing Study.
Main Results:
- ThickNet achieved an AUC of 0.74 for discriminating md-aMCI from healthy controls (NC).
- The classifier yielded AUCs of 0.67 for sd-aMCI/NC and 0.67 for sd-aMCI/md-aMCI discrimination.
- Demonstrated improved performance over methods using only cortical thickness.
Conclusions:
- The ThickNet classifier shows potential for discriminating md-aMCI from controls and sd-aMCI from md-aMCI.
- This approach, using baseline MRI and novel cortical features, may enable earlier detection of AD.
- ThickNet offers a promising tool for improved discrimination of aMCI subtypes.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
Related Concept Videos
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Alzheimer Disease l: Introduction
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists